Skip to main content
Veterinary Medicines

Noromylin Vet. injektionsvæske, opløsning 100 mg/ml

Authorised
  • Lincomycin hydrochloride
  • Lincomycin hydrochloride

Product identification

Medicine name:
Noromylin Vet. injektionsvæske, opløsning 100 mg/ml
Noromylin Vet. 100 mg/ml injektionsvæske, opløsning
Active substance:
  • Lincomycin hydrochloride
  • Lincomycin hydrochloride
Target species:
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    113.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin hydrochloride
    113.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        6
        day
      • Meat and offal
        6
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Scanvet Animal Health A/S
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Alfasan International B.V.
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 15503
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, OPLØSNING 100 MG-ML)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."